Willow Biosciences Inc.
CANSF
$0.02
-$0.0035-14.89%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.57% | 29.78% | 25.91% | 29.51% | 1.84% |
| Total Depreciation and Amortization | -98.12% | 125.93% | -10.78% | -1.19% | -3.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 328.99% | -119.75% | -1.13% | 119.92% | -3.60% |
| Change in Net Operating Assets | -15.35% | 286.01% | -126.17% | 133.99% | -77.18% |
| Cash from Operations | 88.86% | 64.26% | -24.27% | 58.71% | -56.19% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 1,862.75% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 156.81% | -- | -- | -- |
| Cash from Investing | -- | 146.43% | -- | -- | 2,175.00% |
| Total Debt Issued | -- | -274.75% | 99.82% | -- | -- |
| Total Debt Repaid | -0.38% | -33.33% | 1.00% | -1.01% | -3.66% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.99% | 850.59% | -25,200.00% | -100.37% | 1,069.57% |
| Cash from Financing | 107.07% | -141.61% | 86.71% | 379.89% | -78.34% |
| Foreign Exchange rate Adjustments | -109.81% | 678.38% | -227.59% | -78.36% | 143.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 200.35% | -- | -- |
| Net Change in Cash | 68.31% | -403.31% | 118.23% | 39.92% | -188.18% |